樱桃视频

August 30, 2016

Drug quickly counteracts deadly bleeding in people on blood-thinners

An experimental drug designed to quickly counteract blood-thinning medicines has demonstrated effectiveness, according to preliminary results of a new trial done under real-world conditions.

August 29, 2016

Glaxo bets it can shake up HIV treatment

GlaxoSmithKline PLC is pinning the future of its HIV business on an audacious bet: upending the decades-old treatment strategy that has turned a fatal illness into a chronic condition.

August 26, 2016

FDA warns former Sun Pharma US drug factory over quality concerns

The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.

August 25, 2016

Women have more allergies to common medications, study says

A study of more than 1.7 million patients found that women had significantly more allergies to common medications than men.

August 25, 2016

Over 14,000 women took Sanofi epilepsy drug despite fetus risk: ministry

More than 14,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 even though the risk of fetus malformation was known, according to a study released by France on Wednesday.

August 24, 2016

How EpiPen's maker raised prices, and hackles, so much

Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.

August 24, 2016

Can anything contain US drug costs?

The U.S., which spends more on drugs than any other country, might contain costs by limiting market exclusivity for brand name medicines and changing coverage requirements for government health plans, some doctors argue.

August 23, 2016

Pfizer boosts cancer drug roster with $14B Medivation deal

Pfizer Inc, beating out numerous other bidders, said it would buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.

August 23, 2016

US lawmakers press Mylan on EpiPen price increases

Two senior lawmakers on the U.S. Senate's Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions.

August 22, 2016

After a fracture, patients often continue meds that boost fracture risk

Older people who break a bone are often receiving medications that can increase the risk of a fracture - and even after an accident, less than 10 percent of them stop taking those drugs, according to a new study.